Samy Ahmed A, El-Enbaawy Mona I, El-Sanousi Ahmed A, Nasef Soad A, Naguib Mahmoud M, Abdelwhab E M, Hikono Hirokazu, Saito Takehiko
Reference Laboratory for Veterinary Quality Control on Poultry Production, Animal Health Research Institute, Dokki, Giza 12618, Egypt.
Microbiology Department, Faculty of Veterinary Medicine, Cairo University, Giza 12211, Egypt.
Vet Microbiol. 2016 Feb 1;183:103-9. doi: 10.1016/j.vetmic.2015.12.005. Epub 2015 Dec 12.
In Egypt, two distinct lineages of H5N1 highly pathogenic avian influenza (HPAI) viruses, "classic 2.2.1.2" and "variant 2.2.1.1" strains, have evolved. The underlying host immune responses counteracting these viruses in chickens remain not well understood. In the present study, the cytokine responses to a classic strain (C121) and those to a variant strain (V1063) were compared in naïve and vaccinated chickens. In naïve chickens, the C121 replicated more efficiently than the V1063. Both the C121 and the V1063 increased interferon (IFN)-γ and interleukin (IL)-10 gene expression at 48 h post inoculation (hpi) in the lung and spleen but the levels of these cytokines were lower in chickens infected with the C121 than those infected with the V1063. In contrast, in chickens vaccinated with inactivated C121-based vaccine, the C121 replicated less than the V1063. Both challenge with the C121 and that with the V1063 did not increase IFN-γ gene expression at 48 hpi; rather, the C121 increased IL-4 gene expression in the lung accompanied with lower viral titer and higher HI titers. These results suggested that the pathogenicity of HPAI viruses correlated with IFN-γ-producing helper and/or cytotoxic T cell responses in naïve chickens, whereas vaccine efficacy to HPAI viruses correlated with IL-4 producing helper T cell responses in the lung in vaccinated chickens. It implies that IL-4 in the lung, in addition to the traditional serum HI titers, could be used to screen novel vaccine strategies, such as strains, adjuvant, prime/boost protocols, against HPAI in chickens.
在埃及,H5N1高致病性禽流感(HPAI)病毒已经进化出两种不同的谱系,即“经典2.2.1.2”和“变异2.2.1.1”毒株。目前尚不清楚鸡体内对抗这些病毒的潜在宿主免疫反应。在本研究中,比较了未免疫和已免疫鸡对经典毒株(C121)和变异毒株(V1063)的细胞因子反应。在未免疫鸡中,C121的复制效率高于V1063。接种后48小时(hpi),C121和V1063均能增加肺和脾中干扰素(IFN)-γ和白细胞介素(IL)-10基因的表达,但感染C121的鸡体内这些细胞因子的水平低于感染V1063的鸡。相反,在接种基于C121的灭活疫苗的鸡中,C121的复制少于V1063。用C121和V1063进行攻毒在48 hpi时均未增加IFN-γ基因的表达;相反,C121增加了肺中IL-4基因的表达,同时病毒滴度较低,血凝抑制(HI)滴度较高。这些结果表明,HPAI病毒的致病性与未免疫鸡中产生IFN-γ的辅助性和/或细胞毒性T细胞反应相关,而HPAI病毒疫苗的效力与已免疫鸡肺中产生IL-4的辅助性T细胞反应相关。这意味着,除了传统的血清HI滴度外,肺中的IL-4可用于筛选针对鸡HPAI的新型疫苗策略,如毒株、佐剂、初免/加强免疫方案等。